Depends on who is following who !Surely the exchange rate and American buyer sentiment should not dictate the stock price of this great Aussie company.Same goes for Looksmart !
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%